PROVIDER PROFILE · NPI 1538559919

Biodesix, Inc.

Clinical LaboratoryLouisville, COO

MEDICARE UTILIZATION · PART B · 2024

Total beneficiaries

2,455

Unique beneficiaries

—

Total services

2,480

Distinct HCPCS

Medicare payment

$3.5M

PRESCRIBING · PART D · 2024

No data available for this provider in 2024.

QUALITY · MIPS · 2024

No data available for this provider in 2024.

INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024

No data available for this provider in 2024.

REFERRAL NETWORK

Where Biodesix, Inc.'s patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 11 inbound referrers · 0 outbound destinations.

Receives referrals from

Inbound — who sends patients here

Physician	Patients	Visits
UNIVERSITY OF ALABAMA AT BIRMINGHAM	36	139
Bioreference Health, Llc Clinical Laboratory · Elmwood Park, NJ	32	64
Laboratory Corporation Of America Clinical Laboratory · Dallas, TX	24	35
Robert Cerfolio Thoracic Surgery · New York, NY	21	82
MCLAREN OAKLAND	13	38
Laboratory Corporation Of America Clinical Laboratory · Tampa, FL	12	19
Laboratory Corporation Of America Holdings Clinical Laboratory · Raritan, NJ	12	32
Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL	12	19
SOLSTAS LAB PARTNERS GROUP LLC	12	25
DUKE UNIVERSITY HEALTH SYSTEM INC	12	65
Jennifer Garst Hematology-Oncology · Durham, NC	11	79

Refers patients to

Outbound — where patients go next

No outbound pairs above the suppression threshold.

Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.

CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore

OIG/SAM exclusion screening, sanctions history